Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cocrystal Pharma, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 21 | 21 | 0 |
| Shares | 1.07M | 738.9K | −327.3K (−30.7%) |
| Value | $2.08M | $1.47M | −$609.6K (−29.3%) |
New holders (2)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 20,728 | $41.0K | 0.00% |
| FMR LLC | 4 | $8 | 0.00% |
Sold out (2)
Institutions that held Cocrystal Pharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| The PNC Financial Services Group, Inc. | 18 | $36 |
| GWM Advisors LLC | 18 | $35 |